
Journal of Diagnostics Concepts & Practice››2021,Vol. 20››Issue (05): 480-483.doi:10.16150/j.1671-2870.2021.05.012
• Original articles •Previous ArticlesNext Articles
ZHAO Yingmeia, NIE Hongmingb, ZHANG Juea, HUANG Yana(
)
Received:2021-07-13Online:2021-10-25Published:2022-06-28Contact:HUANG Yan E-mail:sangshen1977@163.comCLC Number:
ZHAO Yingmei, NIE Hongming, ZHANG Jue, HUANG Yan. Detection of five coagulation indices in patients with cirrhosis and its clinical significance[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 480-483.
| [1] | 崔云, 张育才, 祝益民. 重视危重症儿童急性肝功能衰竭的诊断与治疗[J]. 中华急诊医学杂志, 2015,24(6):584-587. |
| [2] | 付政文. 止凝血功能指标在乙肝、肝硬化及肝衰竭患者中的变化规律[J]. 血栓与止血学, 2017,23(4):609-611. |
| [3] | 陈欣, 刘怀平, 刘树业. 肝癌肝硬化患者生化、凝血指标与Child-Pugh分级之间的相关性[J]. 中国老年学杂志, 2013,33(20):4974-4976. |
| [4] | Baki JA, Tapper EB. Contemporary Epidemiology of Cirrhosis[J]. Curr Treat Options Gastroenterol, 2019,17(2):244-253. doi:10.1007/s11938-019-00228-3pmid:30949926 |
| [5] | 徐静, 纪冬, 王春艳, 等. 乙型肝炎肝硬化患者血浆D-二聚体水平变化的临床意义[J]. 临床肝胆病杂志, 2020,36(3):551-555. |
| [6] | 闫永. 血浆D-二聚体与凝血四项联合检测对肝硬化患者的临床价值[J]. 中国冶金工业医学杂志, 2019,36(1):112. |
| [7] | 覃乃辉, 裴正玲, 周达利, 等. AT-Ⅲ活性与D-D含量变化在不同程度肝损伤中的应用[J]. 重庆医学, 2014,43(36):4955-4957. |
| [8] | 中华医学会肝病学分会. 肝硬化诊治指南[J]. 现代医药卫生, 2020,36(2):320-337. |
| [9] | 胡丽, 张雅丽, 谭红阳, 等. 肝炎后肝硬化病人症状群纵向研究进展[J]. 护理研究, 2019,33(6):992-997. |
| [10] | Sinegre T, Duron C, Lecompte T, et al. Increased factor Ⅷ plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis[J]. J Thromb Haemost, 2018,16(6):1132-1140. doi:10.1111/jth.14011pmid:29577605 |
| [11] | 余天会. 探讨血浆D-二聚体检测对肝病诊断的意义[J]. 检验医学与临床, 2014,11(21):2987-2988. |
| [12] | Raya-Sánchez JM, González-Reimers E, Rodríguez-Martín JM, et al. Coagulation inhibitors in alcoholic liver cirrhosis[J]. Alcohol, 1998,15(1):19-23. pmid:9426833 |
| [13] | 邓永东, 彭雪彬, 姚立琼, 等. 乙型肝炎肝硬化患者促凝和抗凝血因子变化分析[J]. 临床肝胆病杂志, 2019, 35(2):345-348. |
| [1] | FAN Zhenjia, LIU Yu, XU Guanqun, WU Wenman, WANG Xuefeng.The analysis of activities of vitamin K-dependent coagulation factors, protein C and protein S in patients on warfarin therapy[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 362-366. |
| [2] | XU Mengyang, HE Bin, HUA Baolai, JI Wei, SHEN Lianjun, SHI Qingqing, SUN Xing, YU Ju, XIE Xiaoyan, SUN Mei, GU Jian.The discrepancy of thrombin time results between two kinds of thrombolyzer in a patient associated with heparin like anticoagulant[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 707-710. |
| [3] | WANG Dengfeng, CUI Wenyan, ZOU Wei, LI Fang, WANG Xuefeng, CAI Xiaohong.Molecular mechanism of Axsubtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 260-265. |
| [4] | .[J]. Journal of Diagnostics Concepts & Practice, 2015, 14(06): 539-544. |
| [5] | .[J]. Journal of Diagnostics Concepts & Practice, 2015, 14(02): 126-130. |
| [6] | .[J]. Journal of Diagnostics Concepts & Practice, 2014, 13(06): 584-587. |
| [7] | .[J]. Journal of Diagnostics Concepts & Practice, 2013, 12(06): 628-630. |
| [8] | .[J]. Journal of Diagnostics Concepts & Practice, 2013, 12(03): 279-283. |
| [9] | .[J]. Journal of Diagnostics Concepts & Practice, 2011, 10(03): 268-272. |
| [10] | .[J]. Journal of Diagnostics Concepts & Practice, 2011, 10(01): 62-64. |
| [11] | .[J]. Journal of Diagnostics Concepts & Practice, 2010, 9(03): 242-246. |
| [12] | .[J]. Journal of Diagnostics Concepts & Practice, 2008, 7(05): 507-510. |
| [13] | .[J]. Journal of Diagnostics Concepts & Practice, 2008, 7(04): 416-420. |
| [14] | .[J]. Journal of Diagnostics Concepts & Practice, 2006, 5(06): 507-510. |
| [15] | .[J]. Journal of Diagnostics Concepts & Practice, 2005, 4(01): 44-46. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||